New drug approvals slower in Canada than Europe, U.S.: Fraser Institute
CALGARY | It takes Health Canada nearly a year to grant marketing approval to prescription drugs while new medicines are often approved faster in Europe and the United States, according to a report from the Fraser Institute, an independent public policy think-tank.